A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera

被引:82
作者
Wang, ZH
Christensen, N
Schiller, JT
Dillner, J
机构
[1] KAROLINSKA INST,CTR MICROBIOL & TUMOR BIOL,S-17177 STOCKHOLM,SWEDEN
[2] MILTON S HERSHEY MED CTR,DEPT PATHOL MICROBIOL & IMMUNOL,HERSHEY,PA 17033
[3] NATL CANC INST,CELLULAR ONCOL LAB,BETHESDA,MD
关键词
D O I
10.1099/0022-1317-78-9-2209
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A type-specific and neutralizing mouse MAb (V5) against human papillomavirus (HPV)type 16 capsids was found to block the serological reactivity of human sera with the corresponding capsids. Out of 352 human serum samples tested for the presence of IgG against HPV-16, more than 75% of reactive sera were completely blocked by the V5 antibody. Type-specific MAbs against HPV-6, -18 and -33 were also found to block serological reactivity with capsids of the corresponding HPV types for the majority of reactive human sera. The results suggest that most antibodies in human sera that are reactive with intact HPV capsids recognize the same or closely related major antigenic determinant(s).
引用
收藏
页码:2209 / 2215
页数:7
相关论文
共 24 条
[1]  
ANDERSSONELLSTR.A, 1996, INT J STD AIDS, V23, P234
[2]   Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls - A longitudinal cohort study [J].
AnderssonEllstrom, A ;
Dillner, J ;
Hagmar, B ;
Schiller, J ;
Sapp, M ;
Forssman, L ;
Milsom, I .
SEXUALLY TRANSMITTED DISEASES, 1996, 23 (03) :234-238
[3]   IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION [J].
BREITBURD, F ;
KIRNBAUER, R ;
HUBBERT, NL ;
NONNENMACHER, B ;
TRINDINHDESMARQUET, C ;
ORTH, G ;
SCHILLER, JT ;
LOWY, DR .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3959-3963
[4]   DIVERGENT HUMAN PAPILLOMAVIRUS TYPE-16 VARIANTS ARE SEROLOGICALLY CROSS-REACTIVE [J].
CHENG, G ;
ICENOGLE, JP ;
KIRNBAUER, R ;
HUBBERT, NL ;
STLOUIS, ME ;
HAN, CL ;
SVARE, EI ;
KJAER, SK ;
LOWY, DR ;
SCHILLER, JT .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06) :1584-1587
[5]   POSTATTACHMENT NEUTRALIZATION OF PAPILLOMAVIRUSES BY MONOCLONAL AND POLYCLONAL ANTIBODIES [J].
CHRISTENSEN, ND ;
CLADEL, NM ;
REED, CA .
VIROLOGY, 1995, 207 (01) :136-142
[6]   Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies [J].
Christensen, ND ;
Dillner, J ;
Eklund, C ;
Carter, JJ ;
Wipf, GC ;
Reed, CA ;
Cladel, NM ;
Galloway, DA .
VIROLOGY, 1996, 223 (01) :174-184
[7]   DETECTION OF HUMAN SERUM ANTIBODIES THAT NEUTRALIZE INFECTIOUS HUMAN PAPILLOMAVIRUS TYPE-11 VIRIONS [J].
CHRISTENSEN, ND ;
KREIDER, JW ;
SHAH, KV ;
RANDO, RF .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :1261-1267
[8]  
Chua KL, 1996, INT J CANCER, V68, P54, DOI 10.1002/(SICI)1097-0215(19960927)68:1<54::AID-IJC11>3.0.CO
[9]  
2-6
[10]   PROSPECTIVE SEROEPIDEMIOLOGICAL EVIDENCE THAT HUMAN PAPILLOMAVIRUS TYPE-16 INFECTION IS A RISK FACTOR FOR ESOPHAGEAL SQUAMOUS-CELL CARCINOMA [J].
DILLNER, J ;
KNEKT, P ;
SCHILLER, JT ;
HAKULINEN, T .
BRITISH MEDICAL JOURNAL, 1995, 311 (7016) :1346-1346